Gerald W. Mclaughlin - Net Worth and Insider Trading
Gerald W. Mclaughlin Net Worth
The estimated net worth of Gerald W. Mclaughlin is at least $28,175 dollars as of 2024-11-05. Gerald W. Mclaughlin is the CEO of Neos Therapeutics Inc and owns about 24,500 shares of Neos Therapeutics Inc (NEOS) stock worth over $28,175. Details can be seen in Gerald W. Mclaughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gerald W. Mclaughlin has not made any transactions after 2018-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gerald W. Mclaughlin
Gerald W. Mclaughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gerald W. Mclaughlin owns 4 companies in total, including Neos Therapeutics Inc (NEOS) , Skye Bioscience Inc (SKYE) , and Aytu BioPharma Inc (AYTU) among others .
Click here to see the complete history of Gerald W. Mclaughlin’s form 4 insider trades.
Insider Ownership Summary of Gerald W. Mclaughlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NEOS | Neos Therapeutics Inc | 2020-03-13 | director & Chief Executive Officer |
| SKYE | Skye Bioscience Inc | 2014-10-31 | director |
| AYTU | Aytu BioPharma Inc | 2021-03-19 | director |
 | | 2022-10-01 | director |
Gerald W. Mclaughlin Latest Holdings Summary
Gerald W. Mclaughlin currently owns a total of 1 stock. Gerald W. Mclaughlin owns 24,500 shares of Neos Therapeutics Inc (NEOS) as of December 6, 2018, with a value of $28,175.
Latest Holdings of Gerald W. Mclaughlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NEOS | Neos Therapeutics Inc | 2018-12-06 | 24,500 | 1.15 | 28,175 |
Holding Weightings of Gerald W. Mclaughlin
Gerald W. Mclaughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Gerald W. Mclaughlin has made a total of 0 transactions in Neos Therapeutics Inc (NEOS) over the past 5 years. The most-recent trade in Neos Therapeutics Inc is the acquisition of 17,097 shares on December 6, 2018, which cost Gerald W. Mclaughlin around $36,075.
Insider Trading History of Gerald W. Mclaughlin
- 1
Gerald W. Mclaughlin Trading Performance
GuruFocus tracks the stock performance after each of Gerald W. Mclaughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald W. Mclaughlin is 5.58%. GuruFocus also compares Gerald W. Mclaughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald W. Mclaughlin within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gerald W. Mclaughlin's insider trading performs compared to the benchmark.
Performance of Gerald W. Mclaughlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.25 | | | | | |
| Relative Return to S&P 500(%) | 15.41 | | | | | |
Gerald W. Mclaughlin Ownership Network
Ownership Network List of Gerald W. Mclaughlin
Ownership Network Relation of Gerald W. Mclaughlin
Gerald W. Mclaughlin Owned Company Details
What does Neos Therapeutics Inc do?
Who are the key executives at Neos Therapeutics Inc?
Gerald W. Mclaughlin is the director & Chief Executive Officer of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include Chief Financial Officer Richard I Eisenstadt , SVP & General Counsel John M Limongelli , and Chief Commercial Officer Thomas P Mcdonnell .
Neos Therapeutics Inc (NEOS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neos Therapeutics Inc Insider Transactions
Gerald W. Mclaughlin Mailing Address
Above is the net worth, insider trading, and ownership report for Gerald W. Mclaughlin. You might contact Gerald W. Mclaughlin via mailing address: 227 Washington Street, Suite 200, Conshohocken Pa 19428.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
